Nic Matich Appointed Non-Executive Director to Lead Australian Investor and Business Development Activities: CFO David Robinson Transitions from ...
Jan. 27 Business Watch: Vioneo moves project to China; GSK to buy Rapt Therapeutics for $2.2 billion
Of the many options, the most satisfying in the opinion of C&EN’s business team is calcium chloride. The chemical is strongly ...
Nic Matich Appointed Non-Executive Director to Lead Australian Investor and Business Development Activities: CFO David Robinson Transitions from Board to Executive Role Temas Resources Corp. is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results